These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 36806388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P.
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [Abstract] [Full Text] [Related]

  • 4. The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives.
    Schubert-Bast S, Rosenow F, Klein KM, Reif PS, Kieslich M, Strzelczyk A.
    Epilepsy Behav; 2019 Feb; 91():94-98. PubMed ID: 29941212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy.
    Jeong A, Wong M.
    Expert Rev Neurother; 2016 Feb; 16(4):437-47. PubMed ID: 26854692
    [Abstract] [Full Text] [Related]

  • 8. Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.
    Specchio N, Nabbout R, Aronica E, Auvin S, Benvenuto A, de Palma L, Feucht M, Jansen F, Kotulska K, Sarnat H, Lagae L, Jozwiak S, Curatolo P.
    Eur J Paediatr Neurol; 2023 Nov; 47():25-34. PubMed ID: 37669572
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC.
    Curatolo P, Aronica E, Jansen A, Jansen F, Kotulska K, Lagae L, Moavero R, Jozwiak S.
    Eur J Paediatr Neurol; 2016 Mar; 20(2):203-211. PubMed ID: 26758984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA.
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Kotulska K, Chmielewski D, Borkowska J, Jurkiewicz E, Kuczyński D, Kmieć T, Łojszczyk B, Dunin-Wąsowicz D, Jóźwiak S.
    Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
    [Abstract] [Full Text] [Related]

  • 20. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT, Jennesson MM, Thiele EA.
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.